Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:receptor_tyrosine_kinase
gptkb:drug |
| gptkbp:approvedBy |
gptkb:China
advanced gastric cancer |
| gptkbp:ATCCode |
L01EX10
|
| gptkbp:CASNumber |
811803-05-1
|
| gptkbp:clinicalTrialPhase |
Phase III
|
| gptkbp:developedBy |
gptkb:Jiangsu_Hengrui_Medicine
|
| gptkbp:hasMolecularFormula |
C24H23N5O
|
| https://www.w3.org/2000/01/rdf-schema#label |
Apatinib
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
VEGFR-2 inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:hand-foot_syndrome
diarrhea fatigue hypertension proteinuria |
| gptkbp:synonym |
YN968D1
|
| gptkbp:target |
gptkb:VEGFR-2
|
| gptkbp:usedFor |
gptkb:cancer
|
| gptkbp:bfsParent |
gptkb:Non-Small_Cell_Lung_Cancer
|
| gptkbp:bfsLayer |
6
|